[LGND] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
08-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -5.77%
YoY- -122.64%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 41,420 33,161 27,003 24,808 24,987 43,484 59,590 -21.54%
PBT 28,119 -30,415 -8,175 -19,871 -18,028 842,713 -56,789 -
Tax 6,033 -6,284 -810 -4,620 -3,609 176,376 -14,307 -
NP 22,086 -24,131 -7,365 -15,251 -14,419 666,337 -42,482 -
Tax Rate -21.46% - - - - -20.93% - -
Total Cost 19,334 57,292 34,368 40,059 39,406 -622,853 102,072 -67.05%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin 53.32 -72.77 -27.27 -61.48 -57.71 1,532.37 -71.29 -
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS 1.38 -1.46 -0.43 -0.81 -0.74 32.59 -2.02 -
EPS Diluted 1.32 -1.46 -0.43 -0.81 -0.74 31.32 -2.02 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.